Heparin Sodium | Caspian Tamin Pharmaceutical Company

stdClass Object ( [nid] => 236 [type] => product [language] => en [uid] => 1 [status] => 1 [created] => 1373588247 [changed] => 1392669301 [comment] => 0 [promote] => 0 [moderate] => 0 [sticky] => 0 [tnid] => 118 [translate] => 0 [vid] => 236 [revision_uid] => 1 [title] => Heparin Sodium [body] =>

Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots both in vitro and in vivo. Heparin acts at multiple sites in the normal coagulation system. Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit thrombosis by inactivating activated Factor X and inhibiting the conversion of prothrombin to thrombin. Once active thrombosis has developed, larger amounts of heparin can inhibit further coagulation by inactivating thrombin and preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot in inhibiting the activation of the fibrin stabilizing factor.

[log] => [revision_timestamp] => 1392669301 [format] => 1 [name] => root [picture] => [data] => a:5:{s:29:"taxonomy_image_disable_images";i:0;s:20:"l10n_client_disabled";i:0;s:13:"form_build_id";s:48:"form-aTcSqa5gxC3qlJ6qWYJHsxgkPEq9KwPBBC-KEX1q3PQ";s:18:"admin_compact_mode";b:1;s:7:"contact";i:0;} [path] => product/heparin-sodium [field_one_image] => Array ( [0] => Array ( [fid] => 198 [uid] => 1 [filename] => heparin_s.jpg [filepath] => sites/default/files/images/heparin_s.jpg [filemime] => image/jpeg [filesize] => 68312 [status] => 1 [timestamp] => 1329492178 [list] => 1 [data] => Array ( [alt] => [title] => ) [i18nsync] => 1 [nid] => 236 [view] => ) ) [field_administration_and_dosage] => Array ( [0] => Array ( [value] => [format] => [safe] => [view] => ) ) [field_brand_name] => Array ( [0] => Array ( [value] => Heparodic® [format] => 1 [safe] =>

Heparodic®

[view] =>

Heparodic®

) ) [field_contraindications] => Array ( [0] => Array ( [value] => Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters. [format] => 1 [safe] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

[view] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

) ) [field_dosage_form] => Array ( [0] => Array ( [value] => Injection 5000U/1ml, Injection 10000U/1ml [format] => 1 [safe] =>

Injection 5000U/1ml, Injection 10000U/1ml

[view] =>

Injection 5000U/1ml, Injection 10000U/1ml

) ) [field_drug_interactions] => Array ( [0] => Array ( [value] => • another blood thinner, such as warfarin ; • digoxin ; • dipyridamole ; • hydroxychloroquine ; • ibuprofen ; • indomethacin ; • nicotine cigarettes, gum, lozenges, or skin patches; • nitroglycerin ; • an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ; • cold, allergy, or sleep medications ; • salicylates such as aspirin. [format] => 1 [safe] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

[view] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

) ) [field_indications] => Array ( [0] => Array ( [value] => Atrial fibrillation with embolization: Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and heart surgery; Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; (In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease; Prophylaxis and treatment of pulmonary embolism; Prophylaxis and treatment of peripheral arterial embolism. [format] => 1 [safe] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

[view] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

) ) [field_packing] => Array ( [0] => Array ( [value] => • Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules [format] => 1 [safe] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

[view] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

) ) [field_pdf] => Array ( [0] => Array ( [fid] => 199 [uid] => 1 [filename] => heparin.pdf [filepath] => sites/default/files/pdf/heparin.pdf [filemime] => application/pdf [filesize] => 504274 [status] => 1 [timestamp] => 1329492387 [list] => 1 [data] => [i18nsync] => 1 [nid] => 236 [view] => ) ) [field_pharmacokinetics] => Array ( [0] => Array ( [value] => Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged. [format] => 1 [safe] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

[view] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

) ) [field_pharmacological_category] => Array ( [0] => Array ( [value] => Anticoagulant [format] => 1 [safe] =>

Anticoagulant

[view] =>

Anticoagulant

) ) [field_precautions] => Array ( [0] => Array ( [value] => Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy. [format] => 1 [safe] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

[view] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

) ) [field_pregnancy_category] => Array ( [0] => Array ( [value] => Category C [format] => 1 [safe] =>

Category C

[view] =>

Category C

) ) [field_references] => Array ( [0] => Array ( [value] => [format] => [safe] => [view] => ) ) [field_side_effects] => Array ( [0] => Array ( [value] => Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out. Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection. • sudden numbness or weakness, especially on one side of the body; • sudden severe headache, confusion, problems with vision, speech, or balance; • chest pain, sudden cough, wheezing, rapid breathing, fast heart rate; • pain, swelling, warmth, or redness in one or both legs; • trouble breathing; • (in an infant) extreme drowsiness, weakness, or gasping for breath; or • fever, chills, runny nose, or watery eyes. Less serious heparin side effects may include: • mild pain, redness, warmth, or skin changes where the heparin was injected; • mild itching of feet; or • bluish-colored skin. [format] => 1 [safe] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

[view] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

) ) [field_storage] => Array ( [0] => Array ( [value] => • Store at 20 to 25 C° • Protect from light and freezing [format] => 1 [safe] =>

• Store at 20 to 25 C°
• Protect from light and freezing

[view] =>

• Store at 20 to 25 C°
• Protect from light and freezing

) ) [field_therapeutic_category] => Array ( [0] => Array ( [value] => Cardiovascular Drugs [format] => 1 [safe] =>

Cardiovascular Drugs

[view] =>

Cardiovascular Drugs

) ) [field_related_products] => Array ( [0] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [view] => ) [1] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [view] => ) [2] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [view] => ) ) [taxonomy] => Array ( [7] => stdClass Object ( [tid] => 7 [vid] => 1 [name] => Cardiovascular Drugs,Electrolytes [description] => [weight] => 5 [language] => [trid] => 0 [v_weight_unused] => 0 ) ) [build_mode] => 0 [readmore] => 1 [content] => Array ( [field_one_image] => Array ( [#type_name] => product [#context] => full [#field_name] => field_one_image [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => -3 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => image_plain [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_one_image [#weight] => 0 [#theme] => imagefield_formatter_image_plain [#item] => Array ( [fid] => 198 [uid] => 1 [filename] => heparin_s.jpg [filepath] => sites/default/files/images/heparin_s.jpg [filemime] => image/jpeg [filesize] => 68312 [status] => 1 [timestamp] => 1329492178 [list] => 1 [data] => Array ( [alt] => [title] => ) [i18nsync] => 1 [nid] => 236 [#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] => ) [#title] => [#description] => [#children] => [#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_one_image [#title] => Image [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] => [#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_brand_name] => Array ( [#type_name] => product [#context] => full [#field_name] => field_brand_name [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => -2 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_brand_name [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Heparodic® [format] => 1 [safe] =>

Heparodic®

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Heparodic®

) [#title] => [#description] => [#children] =>

Heparodic®

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_brand_name [#title] => Brand Name [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Heparodic®

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_dosage_form] => Array ( [#type_name] => product [#context] => full [#field_name] => field_dosage_form [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => -1 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_dosage_form [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Injection 5000U/1ml, Injection 10000U/1ml [format] => 1 [safe] =>

Injection 5000U/1ml, Injection 10000U/1ml

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Injection 5000U/1ml, Injection 10000U/1ml

) [#title] => [#description] => [#children] =>

Injection 5000U/1ml, Injection 10000U/1ml

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_dosage_form [#title] => Dosage Form [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Injection 5000U/1ml, Injection 10000U/1ml

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [#pre_render] => Array ( [0] => content_alter_extra_weights ) [field_pharmacological_category] => Array ( [#type_name] => product [#context] => full [#field_name] => field_pharmacological_category [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 0 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_pharmacological_category [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Anticoagulant [format] => 1 [safe] =>

Anticoagulant

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Anticoagulant

) [#title] => [#description] => [#children] =>

Anticoagulant

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_pharmacological_category [#title] => Pharmacological Category [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Anticoagulant

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [#content_extra_fields] => Array ( [title] => Array ( [label] => Generic Name [description] => Node module form. [weight] => -5 ) [body_field] => Array ( [label] => Pharmacology [description] => Node module form. [weight] => 3 [view] => body ) [revision_information] => Array ( [label] => Revision information [description] => Node module form. [weight] => 18 ) [author] => Array ( [label] => Authoring information [description] => Node module form. [weight] => 19 ) [options] => Array ( [label] => Publishing options [description] => Node module form. [weight] => 20 ) [language] => Array ( [label] => Language [description] => Locale module form. [weight] => -4 ) [translation] => Array ( [label] => Translation settings [description] => Translation module form. [weight] => 21 ) [menu] => Array ( [label] => Menu settings [description] => Menu module form. [weight] => 17 ) [taxonomy] => Array ( [label] => Taxonomy [description] => Taxonomy module form. [weight] => -3 ) [path] => Array ( [label] => Path settings [description] => Path module form. [weight] => 16 ) [custom_breadcrumbs] => Array ( [label] => Custom Breadcrumbs [description] => Custom Breadcrumbs module form. [weight] => 30 ) ) [field_therapeutic_category] => Array ( [#type_name] => product [#context] => full [#field_name] => field_therapeutic_category [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 1 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_therapeutic_category [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Cardiovascular Drugs [format] => 1 [safe] =>

Cardiovascular Drugs

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Cardiovascular Drugs

) [#title] => [#description] => [#children] =>

Cardiovascular Drugs

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_therapeutic_category [#title] => Therapeutic Category [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Cardiovascular Drugs

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_pregnancy_category] => Array ( [#type_name] => product [#context] => full [#field_name] => field_pregnancy_category [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 2 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_pregnancy_category [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Category C [format] => 1 [safe] =>

Category C

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Category C

) [#title] => [#description] => [#children] =>

Category C

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_pregnancy_category [#title] => Pregnancy Category [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Category C

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [body] => Array ( [#weight] => 3 [#value] =>

Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots both in vitro and in vivo. Heparin acts at multiple sites in the normal coagulation system. Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit thrombosis by inactivating activated Factor X and inhibiting the conversion of prothrombin to thrombin. Once active thrombosis has developed, larger amounts of heparin can inhibit further coagulation by inactivating thrombin and preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot in inhibiting the activation of the fibrin stabilizing factor.

[#title] => [#description] => [#printed] => 1 ) [field_pharmacokinetics] => Array ( [#type_name] => product [#context] => full [#field_name] => field_pharmacokinetics [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 4 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_pharmacokinetics [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged. [format] => 1 [safe] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

) [#title] => [#description] => [#children] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_pharmacokinetics [#title] => Pharmacokinetics [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Heparin is not absorbed from the gastrointestinal tract.After intravenous or subcutaneous injection heparin is extensively bound to plasma proteins.It does not cross the placenta and it is not distributed into breast milk.The hlf-life of heparin depends on the dose and route of administration as well as the method of calculation and is subject to wide inter- and-intra individualvariation; a range of 1 to 6 hours with an average of 1.5 hours has been cited.It may be slightly prolonged in renal impairment,decreased in patients with pulmonary embolism, and either increased or decreased in patients with liver disorders.Heparin is taken up by the mainly as metabolites, although after large doses up to 50%may be excreted unchanged.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_indications] => Array ( [#type_name] => product [#context] => full [#field_name] => field_indications [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 5 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_indications [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Atrial fibrillation with embolization: Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation); Prevention of clotting in arterial and heart surgery; Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension; (In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease; Prophylaxis and treatment of pulmonary embolism; Prophylaxis and treatment of peripheral arterial embolism. [format] => 1 [safe] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

) [#title] => [#description] => [#children] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_indications [#title] => Indications [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Atrial fibrillation with embolization:
Treatment of acute and chronic consumption coagulopathies (disseminated intravascular coagulation);
Prevention of clotting in arterial and heart surgery;
Anticoagulant therapy in prophylaxis and treatment of venous thrombosis and its extension;
(In a low-dose regimen) for prevention of postoperative deep venous thrombosis and pulmonary embolism in patients undergoing major abdomino-thoracic surgery or who for other reasons are at risk of developing thromboembolic disease;
Prophylaxis and treatment of pulmonary embolism;
Prophylaxis and treatment of peripheral arterial embolism.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_administration_and_dosage] => Array ( [#type_name] => product [#context] => full [#field_name] => field_administration_and_dosage [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 6 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_administration_and_dosage [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => [format] => [safe] => [#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => ) [#title] => [#description] => [#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_administration_and_dosage [#title] => Administration and Dosage [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#printed] => 1 ) [#title] => [#description] => [#printed] => 1 ) [field_contraindications] => Array ( [#type_name] => product [#context] => full [#field_name] => field_contraindications [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 7 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_contraindications [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters. [format] => 1 [safe] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

) [#title] => [#description] => [#children] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_contraindications [#title] => Contraindications [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Due to the potential toxicity of benzyl alcohol in neonates, solutions containing benzyl alcohol must not be used in this patient population. Parenteral preparations with benzyl alcohol should not be used for fluid or sodium chloride replacement. Heparin sodium should not be used in patients: With hypersensitivity to heparin; With an uncontrollable active bleeding state , except when this is due to disseminated intravascular coagulation; With inability to perform suitable blood-coagulation tests, e.g., whole-blood clotting time, partial thromboplastin time, etc. at required intervals. There is usually no need to monitor effect of low-dose heparin in patients with normal coagulation parameters.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_precautions] => Array ( [#type_name] => product [#context] => full [#field_name] => field_precautions [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 8 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_precautions [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy. [format] => 1 [safe] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

) [#title] => [#description] => [#children] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_precautions [#title] => Precautions [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Do not use unless solution is clear and container is undamaged. Use aseptic technique for single or multiple entry and withdrawal from all containers. Since heparin sodium in this product is derived from animal tissue, it should be used with caution in patients with a history of allergy.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_drug_interactions] => Array ( [#type_name] => product [#context] => full [#field_name] => field_drug_interactions [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 9 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_drug_interactions [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => • another blood thinner, such as warfarin ; • digoxin ; • dipyridamole ; • hydroxychloroquine ; • ibuprofen ; • indomethacin ; • nicotine cigarettes, gum, lozenges, or skin patches; • nitroglycerin ; • an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ; • cold, allergy, or sleep medications ; • salicylates such as aspirin. [format] => 1 [safe] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

) [#title] => [#description] => [#children] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_drug_interactions [#title] => Drug Interactions [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

• another blood thinner, such as warfarin ;
• digoxin ;
• dipyridamole ;
• hydroxychloroquine ;
• ibuprofen ;
• indomethacin ;
• nicotine cigarettes, gum, lozenges, or skin patches;
• nitroglycerin ;
• an antibiotic such as demeclocycline , doxycycline , minocycline , or tetracycline ;
• cold, allergy, or sleep medications ;
• salicylates such as aspirin.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_side_effects] => Array ( [#type_name] => product [#context] => full [#field_name] => field_side_effects [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 10 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_side_effects [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out. Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection. • sudden numbness or weakness, especially on one side of the body; • sudden severe headache, confusion, problems with vision, speech, or balance; • chest pain, sudden cough, wheezing, rapid breathing, fast heart rate; • pain, swelling, warmth, or redness in one or both legs; • trouble breathing; • (in an infant) extreme drowsiness, weakness, or gasping for breath; or • fever, chills, runny nose, or watery eyes. Less serious heparin side effects may include: • mild pain, redness, warmth, or skin changes where the heparin was injected; • mild itching of feet; or • bluish-colored skin. [format] => 1 [safe] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

) [#title] => [#description] => [#children] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_side_effects [#title] => Side Effects [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

Heparin can cause you to have bleeding episodes while you are using it and for several weeks after you stop: nosebleed, blood in your urine or stools, black or tarry stools, or any bleeding that will not stop. Allergic reaction to heparin: nausea, vomiting, sweating, hives, itching, trouble breathing, swelling of your face, lips, tongue, or throat, or feeling like you might pass out.
Some people receiving a heparin injection have had a reaction to the infusion (when the medicine is injected into the vein): nauseated, light-headed, sweaty, or short of breath during or after a heparin injection.

• sudden numbness or weakness, especially on one side of the body;
• sudden severe headache, confusion, problems with vision, speech, or balance;
• chest pain, sudden cough, wheezing, rapid breathing, fast heart rate;
• pain, swelling, warmth, or redness in one or both legs;
• trouble breathing;
• (in an infant) extreme drowsiness, weakness, or gasping for breath; or
• fever, chills, runny nose, or watery eyes.

Less serious heparin side effects may include:
• mild pain, redness, warmth, or skin changes where the heparin was injected;
• mild itching of feet; or
• bluish-colored skin.

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_storage] => Array ( [#type_name] => product [#context] => full [#field_name] => field_storage [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 11 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_storage [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => • Store at 20 to 25 C° • Protect from light and freezing [format] => 1 [safe] =>

• Store at 20 to 25 C°
• Protect from light and freezing

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

• Store at 20 to 25 C°
• Protect from light and freezing

) [#title] => [#description] => [#children] =>

• Store at 20 to 25 C°
• Protect from light and freezing

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_storage [#title] => Storage [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

• Store at 20 to 25 C°
• Protect from light and freezing

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_packing] => Array ( [#type_name] => product [#context] => full [#field_name] => field_packing [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 12 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_packing [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => • Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules [format] => 1 [safe] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

[#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

) [#title] => [#description] => [#children] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

[#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_packing [#title] => Packing [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] =>

• Injection 5000U/1ml, Injection 10000U/1ml: Box of 5 ampoules

[#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_references] => Array ( [#type_name] => product [#context] => full [#field_name] => field_references [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 13 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_references [#weight] => 0 [#theme] => text_formatter_default [#item] => Array ( [value] => [format] => [safe] => [#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => ) [#title] => [#description] => [#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_references [#title] => References [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#printed] => 1 ) [#title] => [#description] => [#printed] => 1 ) [field_pdf] => Array ( [#type_name] => product [#context] => full [#field_name] => field_pdf [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 14 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_pdf [#weight] => 0 [#theme] => filefield_formatter_default [#item] => Array ( [fid] => 199 [uid] => 1 [filename] => heparin.pdf [filepath] => sites/default/files/pdf/heparin.pdf [filemime] => application/pdf [filesize] => 504274 [status] => 1 [timestamp] => 1329492387 [list] => 1 [data] => [i18nsync] => 1 [nid] => 236 [#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => [#children] => ) [#title] => [#description] => [#children] => [#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_pdf [#title] => PDF [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#children] => [#printed] => 1 ) [#title] => [#description] => [#children] => [#printed] => 1 ) [field_related_products] => Array ( [#type_name] => product [#context] => full [#field_name] => field_related_products [#post_render] => Array ( [0] => content_field_wrapper_post_render ) [#weight] => 15 [field] => Array ( [#description] => [items] => Array ( [0] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_related_products [#weight] => 0 [#theme] => nodereference_formatter_default [#item] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [#delta] => 0 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => ) [1] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_related_products [#weight] => 1 [#theme] => nodereference_formatter_default [#item] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [#delta] => 1 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => ) [2] => Array ( [#formatter] => default [#node] => stdClass Object *RECURSION* [#type_name] => product [#field_name] => field_related_products [#weight] => 2 [#theme] => nodereference_formatter_default [#item] => Array ( [nid] => [i18nsync] => 1 [safe] => Array ( ) [#delta] => 2 ) [#title] => [#description] => [#theme_used] => 1 [#printed] => 1 [#type] => [#value] => [#prefix] => [#suffix] => ) [#title] => [#description] => [#printed] => 1 ) [#single] => 1 [#attributes] => Array ( ) [#required] => [#parents] => Array ( ) [#tree] => [#context] => full [#page] => 1 [#field_name] => field_related_products [#title] => Related Products [#access] => 1 [#label_display] => above [#teaser] => [#node] => stdClass Object *RECURSION* [#type] => content_field [#printed] => 1 ) [#title] => [#description] => [#printed] => 1 ) [#title] => [#description] => [#children] =>

Heparin inhibits reactions that lead to the clotting of blood and the formation of fibrin clots both in vitro and in vivo. Heparin acts at multiple sites in the normal coagulation system. Small amounts of heparin in combination with antithrombin III (heparin cofactor) can inhibit thrombosis by inactivating activated Factor X and inhibiting the conversion of prothrombin to thrombin. Once active thrombosis has developed, larger amounts of heparin can inhibit further coagulation by inactivating thrombin and preventing the conversion of fibrinogen to fibrin. Heparin also prevents the formation of a stable fibrin clot in inhibiting the activation of the fibrin stabilizing factor.

[#printed] => 1 ) [links] => Array ( [node_translation_fa] => Array ( [title] => فارسی [href] => node/118 [language] => stdClass Object ( [language] => fa [name] => Persian [native] => فارسی [direction] => 1 [enabled] => 1 [plurals] => 0 [formula] => [domain] => [prefix] => fa [weight] => 3 [javascript] => ) [attributes] => Array ( [title] => هپارین سدیم [class] => translation-link ) ) ) )